SCHEMBL27769005

SCHEMBL27769005

CCCNc1ccc(-n2ncc3c(OC4CCN(C(=O)OCCC)CC4)ncnc32)cc1

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 14/20 0.69
ALDH1A1 P00352 4/20 0.51
HSD17B10 Q99714 2/20 0.51
HPGD P15428 2/20 0.51
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
SMN1; SMN2 Q16637 3/20 0.50
KDM4E B2RXH2 2/20 0.50
CYP2C9 P11712 1/20 0.47
KCNH2 Q12809 1/20 0.47
MAPT P10636 4/20 0.46
LMNA P02545 2/20 0.46
MAPK1 P28482 2/20 0.46
POLB P06746 1/20 0.46
TDP1 Q9NUW8 1/20 0.43
TSHR P16473 1/20 0.42
NR2F2 P24468 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL391165 0.89 GPR119 (0.71) GPR119ALDH1A1HSD17B10HPGDNPC1
SCHEMBL386088 0.86 GPR119 (0.91) GPR119CYP2C9KCNH2
SCHEMBL390792 0.83 GPR119 (0.69) GPR119NPC1RAB9AKDM4ECYP2C9
SCHEMBL389883 0.81 GPR119 (1.00) GPR119CYP2C9KCNH2
SCHEMBL12835887 0.81 GPR119 (0.79) GPR119ALDH1A1HSD17B10HPGDNPC1
SCHEMBL390865 0.81 GPR119 (0.95) GPR119CYP2C9KCNH2
SCHEMBL389690 0.80 GPR119 (1.00) GPR119ALDH1A1HSD17B10HPGDNPC1
SCHEMBL391174 0.78 GPR119 (0.64) GPR119ALDH1A1SMN1; SMN2CYP2C9KCNH2
SCHEMBL13685456 0.78 GPR119 (0.51) GPR119ALDH1A1HSD17B10HPGDSMN1; SMN2
SCHEMBL389635 0.78 GPR119 (0.83) GPR119CYP2C9KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101420941-A Use of GPR119 receptor agonists for increasing bone mass and for treating osteoporosis, and related combination therapies ARENA PHARM INC (US) 2009-04-29 CN disclosed